Nevro Corp (NYSE: NVRO) kicked off on Tuesday, remained unchanged from the previous trading day, before settling in for the closing price of $5.72. Over the past 52 weeks, NVRO has traded in a range of $3.16-$17.75.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales growth of Healthcare Sector giant was 2.32%. While this was happening, its average annual earnings per share was recorded 4.68%. With a float of $35.65 million, this company’s outstanding shares have now reached $37.44 million.
Let’s determine the extent of company efficiency that accounts for 1215 employees. In terms of profitability, gross margin is 66.35%, operating margin of -19.83%, and the pretax margin is -17.88%.
Nevro Corp (NVRO) Insider Activity
Our next focus will be how large-scale investors are participating in this stock of the Medical Devices Industry. The insider ownership of Nevro Corp is 5.84%, while institutional ownership is 98.28%.
Nevro Corp (NVRO) Earnings and Forecasts
According to the Wall Street analysts, stocks earnings will be around 4.68% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 5.85% during the next five years compared to -9.37% drop over the previous five years of trading.
Nevro Corp (NYSE: NVRO) Trading Performance Indicators
Take a look at Nevro Corp’s (NVRO) current performance indicators. Last quarter, stock had a quick ratio of 3.76. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 0.52.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.89, a number that is poised to hit -0.77 in the next quarter and is forecasted to reach -2.46 in one year’s time.
Technical Analysis of Nevro Corp (NVRO)
Looking closely at Nevro Corp (NYSE: NVRO), its last 5-days average volume was 4.1 million, which is a jump from its year-to-date volume of 1.22 million. As of the previous 9 days, the stock’s Stochastic %D was 92.23%. Additionally, its Average True Range was 0.28.
During the past 100 days, Nevro Corp’s (NVRO) raw stochastic average was set at 69.34%, which indicates a significant decrease from 92.23% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 61.41% in the past 14 days, which was lower than the 79.00% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $4.39, while its 200-day Moving Average is $6.55. However, in the short run, Nevro Corp’s stock first resistance to watch stands at $5.74. Second resistance stands at $5.75. The third major resistance level sits at $5.77. If the price goes on to break the first support level at $5.71, it is likely to go to the next support level at $5.69. Should the price break the second support level, the third support level stands at $5.68.
Nevro Corp (NYSE: NVRO) Key Stats
The company with the Market Capitalisation of 216.54 million has total of 37,472K Shares Outstanding. Its annual sales at the moment are 425,170 K in contrast with the sum of -92,210 K annual income. Company’s last quarter sales were recorded 96,910 K and last quarter income was -15,340 K.
